Cargando…
Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
Medication-related osteonecrosis of the jaw (MRONJ) frequently affects patients after treatments with bisphosphonates or denosumab, especially with high doses in patients with bone osteoporosis, neoplastic metastases, or possibly anti-angiogenic treatment for cancer. The aim of this article was to s...
Autores principales: | Cortese, Antonio, Casarella, Antonio, Howard, Candace M., Claudio, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146740/ https://www.ncbi.nlm.nih.gov/pubmed/33946237 http://dx.doi.org/10.3390/dj9050050 |
Ejemplares similares
-
The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021) -
The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017) -
Platelet-Rich Fibrin (PRF) in Implants Dentistry in Combination with New Bone Regenerative Flapless Technique: Evolution of the Technique and Final Results
por: Cortese, Antonio, et al.
Publicado: (2017) -
Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis
por: Muñoz-Salgado, Ana, et al.
Publicado: (2023) -
Prevention and management of drug‐induced osteonecrosis of the jaws using platelet‐rich fibrin: A clinical feasibility study
por: Alrmali, Abdusalam, et al.
Publicado: (2023)